However, when hsa-miR-224-5p and pcDNA3.1-CT-GFP-FTH1P3 are cotransfected, the growth inhibition of hsa-miR-224-5p on oral squamous cell carcinoma will be reversed [18]. This evidence concerns the gene FTH1P3 and oral cavity squamous cell carcinoma.